Skip to content
Doctor Evidence
  • Products
    • DOC Search
    • DOC Library
    • DOC Data
    • DOC Label
    • Global Health
    • DOC TRACK
    • DOC Congress
  • Services
    • Reviews
    • Analyses
  • Programs
    • COE
    • GROWTH
    • Training
    • AI
    • SERVE
    • IEM
    • SAW
  • Publications
    • Manuscripts
    • Posters
  • About
    • News
    • Leadership
    • Contact Us
  • Login
Doctor Evidence
Manuscript

Evaluation of Clinical Endpoints as Surrogates for Survival in Patients Treated with Immunotherapies.

Posted November 19, 2017December 3, 2018 Doctor Evidence

AUTHORS: Kaufman,H., Schwartz, L.H.,. William, W.N., Sznol, M, del Aguila, M., Whittington, C., Fahrbach, K,, Xu, Y., Masson, E., Dempster, S., and Vergara-Silva, A. L.

Publication: Journal of Clinical Oncology 35. (suppl; abstr e14557)

YEAR: 2017

Read article
Evaluation of Clinical Endpoints
ImmunotherapyOncology

Post navigation

⟵Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Predictors of Flu Vaccine Uptake in Patients with Diabetes Mellitus⟶

Search our site:

Topics of Interest

Arthritis Arthroplasty Artificial Intelligence Cardiology Cardiovascular COPD Coronary Syndrome Data Mining Diabetes Mellitus Endocrinology Glaucoma guideli Guideline Development Hypertension Immunotherapy Infectious Disease Influenza Lung Cancer Machine Learning Meta-Analysis Nephrology Network Meta-Analysis NSCLC Oncology Ontology Ophthalmology Osteoarthritis Pleural Effusions Respiratory Respiratory Syncytial Virus Rheumatoid Arthritis Rheumatology Stroke Syncope Systematic Review Type 2 Diabetes Mellitus Vaccination

Connect with us

Search our site: